262 related articles for article (PubMed ID: 12488067)
41. A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection.
Ferrari M; Brack A; Romanelli MG; Mettenleiter TC; Corradi A; Dal Mas N; Losio MN; Silini R; Pinoni C; Pratelli A
J Vet Med B Infect Dis Vet Public Health; 2000 Dec; 47(10):753-62. PubMed ID: 11204130
[TBL] [Abstract][Full Text] [Related]
42. Pathogenicity and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant in susceptible animals.
Cong X; Lei JL; Xia SL; Wang YM; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
Vet Microbiol; 2016 Jan; 182():170-7. PubMed ID: 26711045
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of serological tests for the detection of pseudorabies gE antibodies during early infection.
Kinker DR; Swenson SL; Wu LL; Zimmerman JJ
Vet Microbiol; 1997 Apr; 55(1-4):99-106. PubMed ID: 9220601
[TBL] [Abstract][Full Text] [Related]
44. Pathogenicity and immunogenicity of a gI/gE/TK/UL13-gene-deleted variant pseudorabies virus strain in swine.
Lv L; Liu X; Jiang C; Wang X; Cao M; Bai J; Jiang P
Vet Microbiol; 2021 Jul; 258():109104. PubMed ID: 34004569
[TBL] [Abstract][Full Text] [Related]
45. Is recombination of PRV vaccine strains a real problem?
Visser N; Rziha HJ
Acta Vet Hung; 1994; 42(2-3):183-93. PubMed ID: 7810411
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of a killed gpX deleted pseudorabies virus vaccine.
Cook DR; Hill HT; Kinker DR
Can J Vet Res; 1990 Oct; 54(4):438-45. PubMed ID: 2174294
[TBL] [Abstract][Full Text] [Related]
47. Comparison of protection levels against pseudorabies virus infection of transgenic mice expressing a soluble form of porcine nectin-1/HveC and vaccinated mice.
Ono E; Tomioka Y; Taharaguchi S; Cherel P
Vet Microbiol; 2006 May; 114(3-4):327-30. PubMed ID: 16427216
[TBL] [Abstract][Full Text] [Related]
48. Comparison of gE/gI- and TK/gE/gI-Gene-Deleted Pseudorabies Virus Vaccines Mediated by CRISPR/Cas9 and Cre/Lox Systems.
Li J; Fang K; Rong Z; Li X; Ren X; Ma H; Chen H; Li X; Qian P
Viruses; 2020 Mar; 12(4):. PubMed ID: 32230737
[TBL] [Abstract][Full Text] [Related]
49. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
Kit S; Sheppard M; Ichimura H; Kit M
Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
[TBL] [Abstract][Full Text] [Related]
50. Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs.
Kit M; Kit S
Vet Microbiol; 1991 Jul; 28(2):141-55. PubMed ID: 1651582
[TBL] [Abstract][Full Text] [Related]
51. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
[TBL] [Abstract][Full Text] [Related]
52. Comparison of the abilities of serologic tests to detect pseudorabies-infected pigs during the latent phase of infection.
White AK; Ciacci-Zanella J; Galeota J; Ele S; Osorio FA
Am J Vet Res; 1996 May; 57(5):608-11. PubMed ID: 8723868
[TBL] [Abstract][Full Text] [Related]
53. Role of the raccoon in the transmission of pseudorabies: a field and laboratory investigation.
Wright JC; Thawley DG
Am J Vet Res; 1980 Apr; 41(4):581-3. PubMed ID: 6250423
[TBL] [Abstract][Full Text] [Related]
54. A noval strategy of deletion in PK gene for construction of a vaccine candidate with exellent safety and complete protection efficiency against high virulent Chinese pseudorabies virus variant.
Xu M; Zhang C; Liu Y; Chen S; Zheng Y; Wang Z; Cao R; Wang J
Virus Res; 2022 May; 313():198740. PubMed ID: 35271886
[TBL] [Abstract][Full Text] [Related]
55. Immunogenicity and protective efficacy induced by an mRNA vaccine encoding gD antigen against pseudorabies virus infection.
Jiang Z; Zhu L; Cai Y; Yan J; Fan Y; Lv W; Gong S; Yin X; Yang X; Sun X; Xu Z
Vet Microbiol; 2020 Dec; 251():108886. PubMed ID: 33129042
[TBL] [Abstract][Full Text] [Related]
56. The Attenuated Pseudorabies Virus Vaccine Strain Bartha Hyperactivates Plasmacytoid Dendritic Cells by Generating Large Amounts of Cell-Free Virus in Infected Epithelial Cells.
Delva JL; Van Waesberghe C; Van Den Broeck W; Lamote JA; Vereecke N; Theuns S; Couck L; Favoreel HW
J Virol; 2022 Jun; 96(12):e0219921. PubMed ID: 35604216
[TBL] [Abstract][Full Text] [Related]
57. A high-temperature passaging attenuated Pseudorabies vaccine protects piglets completely against emerging PRV variant.
Liang C; Tong W; Zheng H; Liu F; Wu J; Li G; Zhou EM; Tong G
Res Vet Sci; 2017 Jun; 112():109-115. PubMed ID: 28214681
[TBL] [Abstract][Full Text] [Related]
58. [Construction and characterization of a pseudorabies virus TK-/gG- mutant].
Xu XJ; Xu GY; Chen HC; Liu ZF; He QG
Sheng Wu Gong Cheng Xue Bao; 2004 Jul; 20(4):532-5. PubMed ID: 15968983
[TBL] [Abstract][Full Text] [Related]
59. Molecular analysis of pseudorabies viral vaccines and their rapid differentiation from wild-type isolates using DNA-amplified glycoprotein I and thymidine kinase gene segment polymorphisms.
Katz JB; Pedersen JC
Biologicals; 1992 Sep; 20(3):187-95. PubMed ID: 1333775
[TBL] [Abstract][Full Text] [Related]
60. Oral immunization of wild boar and domestic pigs with attenuated live vaccine protects against Pseudorabies virus infection.
Maresch C; Lange E; Teifke JP; Fuchs W; Klupp B; Müller T; Mettenleiter TC; Vahlenkamp TW
Vet Microbiol; 2012 Dec; 161(1-2):20-5. PubMed ID: 22832373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
